Print Print Send link Bookmark and Share

Healthcare and pharmaceutical development

Customer: Zora Biosciences Oy, a VTT spin-off company

Market need: Improved prediction and diagnosis of human health and the development of personalized medicine applications for the pharmaceutical industry.

Application: Zora Biosciences Oy offers advanced laboratory services to meet the needs of pharmaceutical industry in the area of metabolomics and bioinformatics. The company also develops diagnostic applications for healthcare providers, for example, for the prediction of diabetes or cardiovascular disease risk.

Launching the business: The VTT spin-off Zora Biosciences Oy - www.zorabio.com - is one of very few companies in the world spelialized in metabolomics. The metabolomics service market is believed to grow to 1 billion USD by 2011. The in vitro diagnostics market was valued at 29 billion USD in 2005.


Additional information

Tapio Koivu
Executive Vice President
+358 20 722 6943

Reini Hurme, Zora Biosciences Oy
Managing Director
+358 20 722 6943

Additional information

Tapio Koivu
Executive Vice President
+358 20 722 6943

Reini Hurme, Zora Biosciences Oy
Managing Director
+358 20 722 6943